Nebulized opioids in the treatment of dyspnea

Journal of Palliative Care

Volumn 13, Issue 3, 1997, Pages 48-52

  Quelch, Peter C ^a   Faulkner, Donald E ^a   Yun, John W S ^a  

^a Richmond Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; MORPHINE; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DYSPNEA; FEMALE; HUMAN; LUNG FIBROSIS; LUNG TUMOR; LYMPHATIC SYSTEM DISEASE; MALE; MEDIASTINUM DISEASE; MIDDLE AGED; NEBULIZER; OXYGEN THERAPY; SMALL CELL CARCINOMA; TIME; TRACHEA TUMOR;

AGED; ANALGESICS, OPIOID; CARCINOMA, SMALL CELL; DYSPNEA; FEMALE; HUMANS; HYDROMORPHONE; LUNG DISEASES, OBSTRUCTIVE; LUNG NEOPLASMS; LYMPHATIC DISEASES; MALE; MEDIASTINAL DISEASES; MIDDLE AGED; MORPHINE; NEBULIZERS AND VAPORIZERS; OXYGEN INHALATION THERAPY; PULMONARY FIBROSIS; TIME FACTORS; TRACHEAL NEOPLASMS;

EID: 0031230043     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585979701300308     Document Type: Article

References (10)

1. Hockley JM, Dunlop R, Davies RJ. Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team. Br Med J 1988; 296: 1715-1717.
2. Ahmedzai S. Palliation of respiratory symptoms. In: Doyle D, Hanks GWC, MacDonald, N (eds). Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1993; pp. 349-377, 362-364.
3. Twycross R. Pain relief in advance of cancer. Edinburgh: Churchill Livingstone, 1994; p. 393.
4. Davis CL. The therapeutics of dyspnea. In: Cancer Surveys, Volume 21: Palliative Medicine: Problem areas in pain and symptom management. London: Imperial Cancer Research Fund, 1994; pp. 85-98.
5. Farncombe M, Chater S, Gillis A. The use of nebulized opioids for breathlessness: a chart review. Palliat Med 1994; 8: 306-312.
6. Davis CL, Penn K, A'Hern R, Daniels J, Slevin M. Single-dose randomized controlled trial of nebulized morphine in patients with cancer-related breathlessness. Palliat Med 1996; 10: 64-65.
7. Johansson IGM, Grundstrom N, Annersson RRG. Modulation of the airways excitatory neuronal pathways via alpha-2 adrenoceptors and opioid receptors. Acta Physiol Scand 1988; 134 (suppl. 575): 29.
8. Rogers DF, Barnes PJ. Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet 1989; 1: 930-931.
9. Chrubasik J, Wust H, Friedrich G, Geller E. Absorption and bioavailability of nebulized morphine. Br J Anaesth 1988; 61: 228-230.
10. Hughes S, Calverly PMA. Heroin inhalation and asthma. Br Med J 1988; 297: 1511-1512.